Euglycemic diabetic ketoacidosis following major vascular surgery is a new item on the differential for postoperative acidosis

New pharmacologic advances in the treatment of diabetes include SGLT-2 inhibitors, which have been demonstrated in randomized-controlled clinical trials to reduce overall and cardiac-specific mortality and slow progression of chronic kidney disease. Euglycemic diabetic ketoacidosis is a rare but lif...

Full description

Saved in:
Bibliographic Details
Main Authors: Clara M. Gomez-Sanchez, MD, Bian X. Wu, MD, Jeffrey E. Gotts, MD, Robert W. Chang, MD
Format: article
Language:EN
Published: Elsevier 2021
Subjects:
Online Access:https://doaj.org/article/3006de9df1f84acda593c0de6bbb7600
Tags: Add Tag
No Tags, Be the first to tag this record!